Wellington Management Group’s ADMA Biologics ADMA Stock Holding History

Wellington Management Group’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$858K	Sell	95,213 -2,116	-2%	-$33.4K	﹤0.01%	1705
2025 Q4	$1.78M	Sell	97,329 -5,974	-6%	-$101K	﹤0.01%	1622
2025 Q3	$1.51M	Sell	103,303 -828,636	-89%	-$14.2M	﹤0.01%	1704
2025 Q2	$17M	Buy	931,939 +838,118	+893%	+$17.1M	﹤0.01%	1024
2025 Q1	$1.86M	Sell	93,821 -11,638	-11%	-$201K	﹤0.01%	1576
2024 Q4	$1.81M	Sell	105,459 -13,834	-12%	-$260K	﹤0.01%	1589
2024 Q3	$2.38M	Sell	119,293 -478,935	-80%	-$7.45M	﹤0.01%	1504
2024 Q2	$6.69M	Sell	598,228 -14,530	-2%	-$122K	﹤0.01%	1253
2024 Q1	$4.04M	Buy	612,758 +398,773	+186%	+$2.18M	﹤0.01%	1372
2023 Q4	$967K	Buy	+213,985	New	+$792K	﹤0.01%	1631

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group's ADMA Position: Q1 2026 in Review

Wellington Management Group reduced its ADMA Biologics (ADMA) stake by 2.2% in Q1 2026, selling an estimated $33.4K and leaving 95,213 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Wellington Management Group first reported a position in ADMA in Q4 2023 and has held it in 10 quarters since. The position peaked at $17M in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

Wellington Management Group held 95,213 shares of ADMA Biologics worth $858K as of Q1 2026.
Wellington Management Group sold 2,116 ADMA Biologics shares in Q1 2026, an estimated $33.4K.
ADMA Biologics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1705 holding.
Wellington Management Group first reported a position in ADMA Biologics in Q4 2023 and has held it in 10 quarters since.
Wellington Management Group's ADMA Biologics position peaked at $17M in Q2 2025.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.